Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Moleculin Biotech (MBRX) Interest Expenses (2016 - 2023)

Moleculin Biotech (MBRX) has 2 years of Interest Expenses data on record, last reported at -$2000.0 in Q4 2017.

  • For Q4 2017, Interest Expenses fell 133.33% year-over-year to -$2000.0; the TTM value through Sep 2018 reached -$2000.0, down 125.0%, while the annual FY2016 figure was $43000.0, N/A changed from the prior year.
  • Interest Expenses reached -$2000.0 in Q4 2017 per MBRX's latest filing, down from $1000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $37000.0 in Q3 2016 and bottomed at -$2000.0 in Q4 2017.